Immunohistochemical staining reflects the shared genetic basis of the two cancers, and positive staining for OCT3/4 and SALL4 as well as strong membrane positivity for c-KIT (CD117) and D2-40 are used clinically to define both seminoma and dysgerminoma (20, 21). This evidence concerns the gene KIT and seminoma.